Hideki Nagao - 13 Jun 2023 Form 4 Insider Report for MEDICINOVA INC (MNOV)

Role
Director
Signature
/s/ Yuichi Iwaki, attorney-in-fact
Issuer symbol
MNOV
Transactions as of
13 Jun 2023
Net transactions value
$0
Form type
4
Filing time
15 Jun 2023, 18:03:50 UTC
Previous filing
30 Nov 2022
Next filing
12 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNOV Stock Option (Right to Buy) Award $0 +20,000 $0.000000 20,000 13 Jun 2023 Common Stock 20,000 $2.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, subject to continued service with the Company.